Logo image of TOUR

TUNIU CORP-SPON ADR (TOUR) Stock Fundamental Analysis

NASDAQ:TOUR - Nasdaq - US89977P1066 - ADR - Currency: USD

0.926  0 (-0.34%)

Fundamental Rating

5

Overall TOUR gets a fundamental rating of 5 out of 10. We evaluated TOUR against 135 industry peers in the Hotels, Restaurants & Leisure industry. TOUR has an average financial health and profitability rating. TOUR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

TOUR had positive earnings in the past year.
TOUR had a positive operating cash flow in the past year.
TOUR had negative earnings in 4 of the past 5 years.
In multiple years TOUR reported negative operating cash flow during the last 5 years.
TOUR Yearly Net Income VS EBIT VS OCF VS FCFTOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

With a decent Return On Assets value of 4.03%, TOUR is doing good in the industry, outperforming 64.44% of the companies in the same industry.
With a decent Return On Equity value of 7.12%, TOUR is doing good in the industry, outperforming 65.93% of the companies in the same industry.
The Return On Invested Capital of TOUR (6.07%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROIC 6.07%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
TOUR Yearly ROA, ROE, ROICTOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

With an excellent Profit Margin value of 14.98%, TOUR belongs to the best of the industry, outperforming 89.63% of the companies in the same industry.
With a decent Operating Margin value of 15.18%, TOUR is doing good in the industry, outperforming 68.15% of the companies in the same industry.
Looking at the Gross Margin, with a value of 69.65%, TOUR belongs to the top of the industry, outperforming 82.22% of the companies in the same industry.
TOUR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
TOUR Yearly Profit, Operating, Gross MarginsTOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TOUR is destroying value.
TOUR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TOUR has less shares outstanding
Compared to 1 year ago, TOUR has an improved debt to assets ratio.
TOUR Yearly Shares OutstandingTOUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOUR Yearly Total Debt VS Total AssetsTOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

TOUR has an Altman-Z score of -4.74. This is a bad value and indicates that TOUR is not financially healthy and even has some risk of bankruptcy.
TOUR's Altman-Z score of -4.74 is on the low side compared to the rest of the industry. TOUR is outperformed by 94.81% of its industry peers.
There is no outstanding debt for TOUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -4.74
ROIC/WACC0.78
WACC7.75%
TOUR Yearly LT Debt VS Equity VS FCFTOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 1.35 indicates that TOUR should not have too much problems paying its short term obligations.
TOUR has a Current ratio of 1.35. This is in the better half of the industry: TOUR outperforms 68.89% of its industry peers.
A Quick Ratio of 1.35 indicates that TOUR should not have too much problems paying its short term obligations.
TOUR has a better Quick ratio (1.35) than 71.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
TOUR Yearly Current Assets VS Current LiabilitesTOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

TOUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.78%, which is quite impressive.
Looking at the last year, TOUR shows a quite strong growth in Revenue. The Revenue has grown by 16.45% in the last year.
Measured over the past years, TOUR shows a very negative growth in Revenue. The Revenue has been decreasing by -25.77% on average per year.
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%

3.2 Future

Based on estimates for the next years, TOUR will show a very negative growth in Earnings Per Share. The EPS will decrease by -21.60% on average per year.
TOUR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.31% yearly.
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOUR Yearly Revenue VS EstimatesTOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
TOUR Yearly EPS VS EstimatesTOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 2025 2026 2027 0 -5 -10 -15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.29 indicates a reasonable valuation of TOUR.
92.59% of the companies in the same industry are more expensive than TOUR, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.82, TOUR is valued rather cheaply.
The Price/Forward Earnings ratio is 81.53, which means the current valuation is very expensive for TOUR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TOUR indicates a slightly more expensive valuation: TOUR is more expensive than 67.41% of the companies listed in the same industry.
TOUR is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.29
Fwd PE 81.53
TOUR Price Earnings VS Forward Price EarningsTOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOUR is valued a bit cheaper than the industry average as 69.63% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TOUR indicates a rather cheap valuation: TOUR is cheaper than 93.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.32
EV/EBITDA 9.3
TOUR Per share dataTOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TOUR's earnings are expected to decrease with -21.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%

More info and screens

3

5. Dividend

5.1 Amount

TOUR has a Yearly Dividend Yield of 3.27%.
Compared to an average industry Dividend Yield of 3.73, TOUR pays a better dividend. On top of this TOUR pays more dividend than 85.93% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, TOUR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

TOUR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TOUR Yearly Dividends per shareTOUR Yearly Dividends per shareYearly Dividends per share 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
TOUR Yearly Income VS Free CF VS DividendTOUR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

More info and screens

TUNIU CORP-SPON ADR

NASDAQ:TOUR (5/23/2025, 8:59:42 PM)

0.926

0 (-0.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-11 2025-03-11/bmo
Earnings (Next)06-02 2025-06-02
Inst Owners12.2%
Inst Owner Change-24.43%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap109.00M
Analysts85.71
Price Target1.73 (86.83%)
Short Float %0.45%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27 2025-03-27 (0.036)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-92.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.17%
Valuation
Industry RankSector Rank
PE 10.29
Fwd PE 81.53
P/S 1.52
P/FCF 9.32
P/OCF 8.16
P/B 0.73
P/tB 0.81
EV/EBITDA 9.3
EPS(TTM)0.09
EY9.72%
EPS(NY)0.01
Fwd EY1.23%
FCF(TTM)0.1
FCFY10.73%
OCF(TTM)0.11
OCFY12.26%
SpS0.61
BVpS1.28
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROCE 7.68%
ROIC 6.07%
ROICexc 6.07%
ROICexgc 6.82%
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
FCFM 16.34%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
F-Score8
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 192.93%
Cap/Sales 2.33%
Interest Coverage 26.17
Cash Conversion 113.99%
Profit Quality 109.09%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -4.74
F-Score8
WACC7.75%
ROIC/WACC0.78
Cap/Depr(3y)99.5%
Cap/Depr(5y)69.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A
EBIT growth 1Y477.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year527.57%
EBIT Next 3Y112.1%
EBIT Next 5YN/A
FCF growth 1Y-62.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.8%
OCF growth 3YN/A
OCF growth 5YN/A